Mycoplasma Testing - Global Market Outlook (2016-2022)

Report ID : RNR-64748 Category : Biotechnology Published Date : March 2017
Publisher : Stratistics MRC Pages : 0 Format : PDF
According to Stratistics MRC, the Global Mycoplasma Testing market is accounted for $427.2 million in 2016 and is expected to reach $911.7 million by 2022 growing at a CAGR of 13.5% from 2016 to 2022. Rising R&D investments in life sciences, increasing healthcare expenditure levels, increased number of patients suffering from infectious diseases, rapidly increasing new drug launches, increasing applications of PCR technologies in the field of life science, growing biotechnology & pharmaceutical companies, technological advancements and increasing government support are some of the factors favouring the mycoplasma testing market. However, stringent government regulations and high degree of consolidation for new entrants are hampering the market.

Polymerase Chain Reaction (PCR) technology is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth. In 2016, kits & reagents products accounted for the largest market share due to repeated purchase of these products. Pharmaceutical and biotechnology companies hold the largest share in end users segment. Contract research organizations are anticipated to grow at a faster pace during the forecast period.

North America is the largest market for mycoplasma testing market due to increasing demand for fast, accurate and affordable diagnosis in healthcare. In addition, spending in R&D activities is expected to enhance developments and rising government funding for pharmaceutical and biotechnology sector in North America is also boosting the growth of mycoplasma testing markets. Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, funding initiatives generated by the Indian government to promote R&D activities in biopharmaceutical industries.

Some of the significant players in global mycoplasma testing market are Abbott, American Type Culture Collection, Beckman Coulter/Danaher, Becton Dickinson, Biological Industries, Israel Beit Haemek Ltd., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Promo Cell GmbH, Qiagen, Roche, Sigma-Aldrich and Thermo Fisher Scientific, Inc.

Technologies Covered:
• Direct Assay
• Enzymatic Methods
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Indirect Assay
• Microbial Culture Techniques
• Polymerase Chain Reaction (PCR)

Product Types Covered:
• Services
• Instruments         
• Kits & Reagents  
o Elimination Kits & Reagents
o Nucleic Acid Detection Kits
o PCR Assays
o Stains
o Standards & Controls
o Other Kits & Reagents

Applications Covered:
• Virus Testing
• End of Production Cells Testing
• Cell Line Testing
• Other Applications

End Users Covered:
• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
•  Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 Executive Summary    
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities   
 3.5 Threats    
 3.6 Product Analysis   
 3.7 Technology Analysis   
 3.8 Application Analysis   
 3.9 End User Analysis   
 3.10 Emerging Markets   
 3.11 Futuristic Market Scenario  
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes   
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
5 Global Mycoplasma Testing Market, By Technology 
 5.1 Introduction   
 5.2 Direct Assay   
 5.3 Enzymatic Methods   
 5.4 Enzyme-Linked Immunosorbent Assay (ELISA)
 5.5 Indirect Assay   
 5.6 Microbial Culture Techniques  
 5.7 Polymerase Chain Reaction (PCR) 
6 Global Mycoplasma Testing Market, By Product Type
 6.1 Introduction   
 6.2 Services    
 6.3 Instruments             
 6.4 Kits & Reagents      
  6.4.1 Elimination Kits & Reagents 
  6.4.2 Nucleic Acid Detection Kits 
  6.4.3 PCR Assays  
  6.4.4 Stains   
  6.4.5 Standards & Controls 
  6.4.6 Other Kits & Reagents  
7 Global Mycoplasma Testing Market, By Application 
 7.1 Introduction   
 7.2 Virus Testing   
 7.3 End of Production Cells Testing  
 7.4 Cell Line Testing   
 7.5 Other Applications   
8 Global Mycoplasma Testing Market, By End User 
 8.1 Introduction   
 8.2 Academic Research Institutes  
 8.3 Cell Banks   
 8.4 Contract Research Organizations 
 8.5 Pharmaceutical & Biotechnology Companies
 8.6 Other End Users   
9 Global Mycoplasma Testing Market, By Geography 
 9.1 North America   
  9.1.1 US   
  9.1.2 Canada   
  9.1.3 Mexico   
 9.2 Europe    
  9.2.1 Germany   
  9.2.2 France   
  9.2.3 Italy   
  9.2.4 UK   
  9.2.5 Spain   
  9.2.6 Rest of Europe  
 9.3 Asia Pacific   
  9.3.1 Japan   
  9.3.2 China   
  9.3.3 India   
  9.3.4 Australia   
  9.3.5 New Zealand  
  9.3.6 Rest of Asia Pacific  
 9.4 Rest of the World   
  9.4.1 Middle East  
  9.4.2 Brazil   
  9.4.3 Argentina   
  9.4.4 South Africa  
  9.4.5 Egypt   
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers  
 10.3 New Product Launch   
 10.4 Expansions   
 10.5 Other Key Strategies   
11 Company Profiling    
 11.1 Abbott    
 11.2 American Type Culture Collection 
 11.3 Beckman Coulter/Danaher  
 11.4 Becton Dickinson   
 11.5 Biological Industries Israel Beit Haemek Ltd.
 11.6 Bionique Testing Laboratories, Inc. 
 11.7 Charles River Laboratories International, Inc.
 11.8 InvivoGen    
 11.9 Lonza Group Ltd.   
 11.10 Merck KGaA   
 11.11 Promo Cell GmbH   
 11.12 Qiagen    
 11.13 Roche    
 11.14 Sigma-Aldrich   
 11.15 Thermo Fisher Scientific, Inc.